The Future of Neurotech Investing with Jordi Parramon

In this episode of The Open Loop, Chay Carter is joined by Jordi Parramon, a neurotechnology operator, investor, and founder of Nexus NeuroTech Ventures. Jordi brings more than 27 years of experience across medical devices, health tech, and venture, with leadership roles spanning Boston Scientific, Verily, and a portfolio of neurotech companies including Cala Health, INSIGHTEC, Rune Labs, Lotus Neuro, and Galvani. This is a practical conversation about what neurotech needs next, from patient access and indication expansion to reimbursement, market access, consumer devices, and smarter investment thinking. We also explore Jordi’s perspective on the future of neuromodulation, brain data, wearable technologies, BCI, focused ultrasound, and why the next phase of the industry will depend on connecting innovation across the full patient journey. Key takeaways: 🔹 Why neurotech still needs to solve its patient access and penetration problem🔹 How consumer and regulated devices could work together across the healthcare journey🔹 What early-stage neurotech investors look for beyond financial modelling🔹 Why reimbursement and market access are becoming central to funding and M&A🔹 Where Jordi sees the next major opportunities in neuromodulation and neuropsychiatric care Host:Chay CarterFounder, Carter SciencesCo-Founder, Reccy NeuroLinkedIn: https://www.linkedin.com/in/chay-carter/ Guest:Jordi ParramonNeurotechnology investor, operator, and founder of Nexus NeuroTech VenturesLinkedIn: https://www.linkedin.com/in/jordi-parramon-50b2158/ Key Chapters:00:00 Introduction to Jordi Parramon01:16 From Implantable Devices to Neurotech Investment04:28 M&A, Platforms, and Early Neuromodulation Innovation08:57 Patient Access and Indication Diversification11:19 Wearables, Consumer Devices, and Neurohealth16:43 EEG, Brain Data, and the Future of Digital Health18:05 What Investors Look for in Neurotech28:22 Emerging Opportunities and the Future of Neuromodulation The Open Loop is a podcast exploring the people, companies, and ideas shaping the future of neurotechnology. 🔔 Subscribe for weekly conversations with the founders, researchers, and operators building what comes next in brain health, medicine, and technology.